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Abstract
Objective: To assess agreement in diagnosing surgical site infection (SSI) among healthcare professionals involved in SSI
surveillance.
Methods: Case-vignette study done in 2009 in 140 healthcare professionals from seven specialties (20 in each specialty,
Anesthesiologists, Surgeons, Public health specialists, Infection control physicians, Infection control nurses, Infectious
diseases specialists, Microbiologists) in 29 University and 36 non-University hospitals in France. We developed 40 case-
vignettes based on cardiac and gastrointestinal surgery patients with suspected SSI. Each participant scored six randomly
assigned case-vignettes before and after reading the SSI definition on an online secure relational database. The intraclass
correlation coefficient (ICC) was used to assess agreement regarding SSI diagnosis on a seven-point Likert scale and the
kappa coefficient to assess agreement for superficial or deep SSI on a three-point scale.
Results: Based on a consensus, SSI was present in 21 of 40 vignettes (52.5%). Intraspecialty agreement for SSI diagnosis
ranged across specialties from 0.15 (95% confidence interval, 0.00–0.59) (anesthesiologists and infection control nurses) to
0.73 (0.32–0.90) (infectious diseases specialists). Reading the SSI definition improved agreement in the specialties with poor
initial agreement. Intraspecialty agreement for superficial or deep SSI ranged from 0.10 (20.19–0.38) to 0.54 (0.25–0.83)
(surgeons) and increased after reading the SSI definition only among the infection control nurses from 0.10 (20.19–0.38) to
0.41 (20.09–0.72). Interspecialty agreement for SSI diagnosis was 0.36 (0.22–0.54) and increased to 0.47 (0.31–0.64) after
reading the SSI definition.
Conclusion: Among healthcare professionals evaluating case-vignettes for possible surgical site infection, there was large
disagreement in diagnosis that varied both between and within specialties.
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Introduction
Surgical site infection (SSI) is receiving considerable interest
from healthcare authorities, the media, and the public. Because
they are often considered avoidable, the SSI rate has been used
for performance assessments and benchmarking [1], and
several countries require that healthcare facilities publish SSI
rates to improve transparency, and possibly quality of care and
patient safety [2]. However, the evidence that publishing
quality indicators improves care is scant [3]. Recent reports
indicate a need for improved measurement reliability [4], and
mandatory public reporting remains a focus of vigorous debate
[5,6].
Methodological issues, related to benchmarking and public
reporting, remain controversial. If the SSI rate is to serve as a
performance indicator, then valid and consistent SSI rates must be
obtained [2]. SSI rates vary according to co-morbidities, to the
contamination class and conditions of the surgical procedure. The
need for adjustment has been demonstrated, and most surveillance
networks use risk stratification [7,8]. Another factor that influences
SSI rates is the certainty of SSI diagnosis. The extent to which
different healthcare professionals will agree regarding the diagnosis
of SSI depends on many factors including training, experience,
and the use of a common SSI definition. A single-centre study
showed variability in the SSI incidence rate according to the SSI
definition [9].
We designed a study to assess agreement among healthcare
professionals within and among different specialties regarding
diagnosis and superficial or deep SSI, based on case-vignettes
concerning real patients. We also evaluated whether the providing
of NHSN criteria change the agreement estimates
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Development of the case-vignettes
Case-vignettes allow an assessment of the same cases by
healthcare professionals involved in diagnosing and treating SSI.
We used blinded random assignment of the case-vignettes to
healthcare professionals.
We followed consecutive patients with suspected SSI through-
out their hospitalization or re-hospitalization in four surgical units,
two digestive surgery units and two cardiac surgery units in three
French University hospitals. Each day, a bedside evaluation was
performed; the medical chart and nurses’ log were reviewed; and
the findings from laboratory and microbiology tests, and imaging
studies were recorded. Photographs of the wound and/or
computed tomography (CT) results were obtained. We identified
40 patients with suspected SSI and complete information, 20 in
cardiac surgery and 20 with gastrointestinal surgery (colorectal or
bariatric procedures).
Suspected SSI was defined as wound modification or discharge
and/or evidence of infection. We used the Centers for Disease
Control SSI definition (Table S1) [10], which is identical to the
European HELICS/IPSE definition [11,12].
Participants
We identified 20 healthcare professionals from each of seven
specialties potentially involved in SSI management: surgeons in
any specialty, anaesthesiologists, microbiologists, infectious diseas-
es specialists, infection control nurses, infection control physicians,
and public health specialists.
To build our study sample, participants were recruited by direct
solicitation of close colleagues from other hospitals and relation
network. In addition, we used the French network for SSI
surveillance for surgeons’ identification, together with several
French societies for the other specialties, i.e. the Public Health
Society, the French Hygiene Society, the French Society for
Infectious Diseases, the French Society for Microbiology and the
French Society for Anesthesiology and Intensive Care.
No randomized selection was done and the first 20 participants
volunteering to participate were included in the study. Most of the
participants were health-care workers as some of public health
specialists were engineer involved in the risk control in hospitals.
All 140 participants worked full time in public or private French
hospitals with surgical activity, including university and non-
university facilities. None of them had been involved in the
management of patients used to build the vignettes. All the 140
participants scored the assigned case vignettes during a 4-month
period. Because of the observational and blinded nature of the
study, the institutional review board of the Bichat-Claude Bernard
Hospital waived the requirement for informed consent.
Study design and data
Twenty of the 40 vignettes were randomly assigned for assessing
the intra-specialty agreement. These twenty vignettes were scored
twice without the SSI definition by participants for each specialty.
The same 20 vignettes were also scored twice with the SSI
definition by participants inside each specialty. All 40 case
vignettes were randomly assigned for assessing the inter-specialty
reliability of scoring with or without the SSI definition. In total,
each participant scored six vignettes. The first three vignettes were
scored without the SSI definition. Then three other vignettes were
scored with the SSI definition. Of the 6 vignettes read by one
participant, 5 were different, and one was scored twice, first
without the SSI definition then with the SSI definition. In total, 20
vignettes were read four times and 20 vignettes were read two
times by specialty. Consequently, taking into account the seven
specialties, 20 vignettes were scored 28 times and 20 vignettes were
scored 14 times, for a theoretical total of 840 scores.
Scores were assigned using a seven-point Likert scale ranging
from ‘‘SSI certainly absent’’ (score one) to ‘‘SSI certainly present’’
(score seven) [13]. When the score was between four and seven,
the participant scored superficial/deep SSI on a three-point scale
(one, superficial SSI; two, depth unclear; and three, deep or
organ/space-related SSI). We simplified the depth assessment by
putting deep and organ/space-related SSIs in the same group, as
both SSI categories have the same severe consequences in terms of
mortality, morbidity, and prolongation of hospital stay.
An online secure relational database was constructed for
collecting the study data. Each participant had a personal login
and password [14,15]. The patient data were presented chrono-
logically, and the scores assigned before reading the SSI definition
could not be changed. Before scoring the vignettes, each
participant provided the following information: age, gender, type
of hospital, and duration of experience in the current job.
Statistical analysis
We estimated the number of vignettes and participants needed
to assess agreement within specialties, according to the precision of
the intraclass correlation coefficient [16] and taking into account
the feasibility of the study. If 20 vignettes were scored twice and if
the expected coefficient is close to 0.60, then the semi-width of the
exact 95 per cent confidence interval (i.e., the precision) is equal to
0.29.
Data were described as mean 6 SD, median (interquartile
range), or percentage.
Intra- and interspecialty agreement analysis were performed
before and after reading the SSI definition. To evaluate intra- and
interspecialty agreement regarding the one-seven Likert scale, we
computed the intraclass correlation coefficient (ICC). We used the
bootstrap procedure (Bias-corrected and accelerated bootstrap) to
estimate 95% confidence intervals (95%CIs). An ICC value of 0
indicates the level of agreement produced by chance alone and a
value of 1 indicates perfect agreement. We defined poor
agreement as ICC values lower than 0.4, good agreement as
ICC values of 0.4 to 0.7, and very good agreement as ICC values
higher than 0.7 [17].
We also dichotomized the Likert scale (i.e. scores one to four,
corresponding to the absence of SSI and scores five to seven,
corresponding to the presence of SSI). To evaluate intraspecialty
agreement, observed agreement (exact 95% confidence intervals)
and simple kappa coefficient (with 95% confidence intervals) were
computed. To evaluate interspecialty agreement, we computed
kappa for multiple raters with their 95%CIs [18]. Agreement
assessed by Kappa coefficient is considered poor when kappa is
0.20 or less, fair when kappa is 0.21–0.40, moderate when kappa is
0.41–0.60, good when kappa is 0.61–0.80 and very good when the
kappa value is 0.81–1.00 [19].
To evaluate intra- and interspecialty agreement regarding
superficial/deep SSI scored on the 3-point scale, we computed
observed agreement (exact 95% confidence intervals) and kappa
coefficient (with 95% confidence intervals). We added a fourth
category comprising the participants who did not score SSI depth
because their score for SSI diagnosis on the 7-point Likert scale
was lower than 4.
Analyses was performed using SAS System, Version 9.2 (SAS
Institute, Cary, NC) for descriptive and kappa statistics and
graphs. R 1.9 software and its ‘‘boot’’ and ‘‘psy’’ library were used
for computing ICCs.
Agreement in Diagnosing SSI
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Characteristics of the participants and case-vignettes
Table S2 reports the main characteristics of the 140
participants. All 140 participants completed the study. They
originated from 29 University and 36 non University hospitals in
France. There was one participant in 40 hospitals (62%), 2 to 4
participants in 20 (31%) hospitals and 5 or more participants in 5
(7%) hospitals. Their median (IQR) age was 48 (29–65) years and
77 (55%) were male. Their median time in their current job was
17 (1–36) years and 98 (70%) of them were directly involved in SSI
surveillance programs in their healthcare facility. Among the 140
participants, 104 (74%) worked in publicly funded healthcare
facilities, 19 (14%) in private healthcare facilities, and 17 (12%) in
other types of centers.
SSI was suspected before hospital discharge in 36 patients and
after hospital discharge in 4 patients, who required re-admission.
Wound modification was a feature in all 20 cardiac surgery
patients and in 11 (55%) gastrointestinal surgery patients.
Microbiological specimens were obtained from the surgical wound
in all 20 cardiac surgery patients and were positive in 11 (55%) of
these patients. Of the 20 gastrointestinal surgery patients, 3
underwent wound sampling for microbiological tests, which were
positive in 2 patients. Based on the consensus of the two main
investigators (DLP and JCL), there was an agreement in 36 out of
the 40 vignettes, with the presence of SSI in 21 vignettes (52.5%).
Case-vignette scores
In total, the 40 case-vignettes were scored 822 times and not
840 as theoretically scheduled. Due to a computer assignment
glitch, three surgeons were assigned vignettes that had previously
been assigned to other surgeons. Therefore, the 18 vignettes that
these surgeons were supposed to receive were not scored. The
median SSI diagnosis score before reading the SSI definition on
the seven-point Likert scale varied across specialties from four
(IQR, 2–6) for public health specialists and infection control nurses
to seven for anesthesiologists (IQR, 3.5–7) (Table 1).
Intraspecialty and interspecialty agreement regarding SSI
diagnosis
The intraspecialty ICC based on scores assigned without the
SSI definition ranged across specialties from 0.15 to 0.73.
Agreement was very good among infectious diseases specialists
(ICC, 0.73; 95%CI, 0.32–0.90); good among surgeons (0.45, 0.00–
0.81), public health specialists (0.56, 0.18–0.80) and microbiolo-
gists (0.56, 0.19–0.81); and poor among infection control
physicians (0.30, 0.00–0.69), anesthesiologists (,0.20, 0.00–0.59),
and infection control nurses (,0.20) (Table 2). Scoring with the
SSI definition improved agreement only within the specialties
where agreement was poor initially (Table 2).
After dichotomization, results were similar with good agreement
among infectious diseases specialists (0.66, 0.30–1.00), moderate
agreement among microbiologists (0.60, 0.26–0.94) and public
health specialists (0.52, 0.20–0.84), fair agreement among surgeons
(0.38, 20.05–0.80) and infection control physicians (0.21, 20.24–
0.64) and poor agreement in other specialties (Table 3).
Scoring without the SSI definition, the interspecialty ICC was
0.36 (0.22–0.54). Scoring with the definition improved the ICC to
0.47 (0.31–0.64) (Table 2).
Agreement regarding SSI depth
Intraspecialty kappa values for superficial/deep SSI scored
without the SSI definition varied from 0.10 to 0.54 (Table 4).
Agreement was moderate among surgeons (k, 0.54, 0.25–0.83); fair
among public health specialists (0.32, 0.06–0.59), infection control
physicians (0.25, 20.04–0.55), infectious diseases specialists (0.22,
0.04–0.47), and microbiologists (0.21, 20.05–0.46); and poor
within other specialties. Reading the SSI definition was followed
by an increase in the intraspecialty kappa values mainly among the
infection control nurses (Table 4).
Interspecialty kappa values for SSI depth scored before reading
the SSI definition were 0.21 (0.16–0.25). Reading the SSI
definition increased in the interspecialty kappa values to 0.29
(0.27–0.31).
Discussion
In a large panel of healthcare professionals from different
specialties involved in SSI surveillance, agreement regarding the
diagnosis and depth assessment of SSI varied across specialties and
across individuals within each specialty. Scoring with the SSI
definition improved agreement regarding the SSI diagnosis and
depth assessment only in the specialties where agreement was poor
initially.
There is an abundance of studies evaluating SSI risk factors and
risk stratification [20]. In addition, many studies assessed
techniques designed to improve the measurement of the
numerator, i.e., the number of SSIs. The reference standard
method for SSI surveillance includes daily bedside surveillance
Table 1. Distribution of scores assigned before reading the definition of surgical site infection, on a 7-point Likert scale, in each of
the seven specialties.
Specialty Number of vignettes scored* Mean score (SD) Median score (IQR) Min. - Max.
Anesthesiologist 40 5.4 (2.2) 7.0 (3.5–7.0) 1.0–7.0
Surgeon 34** 4.8 (2.3) 5.5 (2.0–7.0) 1.0–7.0
Public health specialist 40 4.1 (2.0) 4.0 (2.0–6.0) 1.0–7.0
Infection control physician 40 4.8 (2.3) 6.0 (2.0–7.0) 1.0–7.0
Infection control nurse 40 4.1 (2.2) 4.0 (2.0–6.0) 1.0–7.0
Infectious diseases specialist 40 4.9 (2.3) 6.0 (2.0–7.0) 1.0–7.0
Microbiologist 40 4.1 (2.4) 4.5 (2.0–6.0) 1.0–7.0
SD, standard deviation; IQR, interquartile range; min, minimum; max, maximum.
*Number of vignettes scored (20 vignettes were scored twice for each specialty).
**missing values due a computer assignment glitch.
doi:10.1371/journal.pone.0035131.t001
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usefulness of surrogate indicators [22,23].
We are aware of a single study evaluating the impact of different
SSI definitions on SSI rates [9]. In this study, SSI rates varied by
more than 50% when small changes were made in the SSI
definition. This study has limitations, however, including the
single-centre design and possible observation bias due to the
expectation that SSI rates would vary according to the SSI
definition. Other studies suggest imperfect agreement across
physicians regarding the diagnosis of SSI. In one study, wide
differences in the diagnosis of SSI were noted between infection
control practitioners and surgeons, as well as across surgeons [24].
Table 2. Assessment of surgical site infection (SSI) diagnosis for 40 vignettes (20 cardiac surgery cases and 20 gastrointestinal
surgery cases) developed based on real patients in three French university hospitals.
SSI diagnosis score, 7-point Likert scale (Intraclass correlation coefficient)
Number of vignettes
scored*
Scoring without the SSI
definition (95%CI)
Number of vignettes
scored*
Scoring with the SSI
definition (95%CI)
Intraspecialty correlation
Anesthesiologist 40 0.15 (0.00–0.59) 40 0.35 (0.00–0.73)
Surgeon 32** 0.45 (0.00–0.81) 28** 0.42 (0.09–0.80)
Public health specialist 40 0.56 (0.18–0.80) 40 0.29 (0.00–0.66)
Infection control physician 40 0.30 (0.00–0.69) 40 0.01 (0.00–0.48)
Infection control nurse 40 0.19 (0.00–0.59) 40 0.56 (0.00–0.80)
Infectious diseases specialist 40 0.73 (0.32–0.90) 40 0.66 (0.22–0.91)
Microbiologist 40 0.56 (0.19–0.81) 40 0.42 (0.00–0.71)
Interspecialty correlation 238** 0.36 (0.22–0.54) 238** 0.47 (0.31–0.64)
*Number of vignettes scored (for intraspecialty 20 vignettes were scored twice and for interspecialty 34 vignettes were scored 7 times).
**missing values due a computer assignment glitch.
doi:10.1371/journal.pone.0035131.t002
Table 3. Assessment of surgical site infection (SSI) diagnosis for 40 vignettes (20 cardiac surgery cases and 20 gastrointestinal
surgery cases) developed based on real patients in three French university hospitals.
SSI diagnosis score, 7-point Likert scale categorized in 2 classes (1,2,3,4 vs 5,6,7)
Scoring without the SSI definition (95%CI)
Number of vignettes scored* Observed agreement (%) (95%CI) Kappa coefficient (95%CI)
Intraspecialty
Anesthesiologist 40 65.0 (40.8–84.6) 0.15 (20.28–0.57)
Surgeon 32** 68.8 (41.3–89.0) 0.38 (20.05–0.80)
Public health specialist 40 75.0 (50.9–91.3) 0.52 (0.20–0.84)
Infection control physician 40 65.0 (40.8–84.6) 0.21 (20.24–0.64)
Infection control nurse 40 55.0 (31.5–76.9) 0.12 (20.30–0.53)
Infectious diseases specialist 40 85.0 (62.1–96.8) 0.66 (0.30–1.00)
Microbiologist 40 80.0 (56.3–94.3) 0.60 (0.26–0.94)
Interspecialty 238** - 0.28 (0.21–0.36)
Scoring with the SSI definition (95%CI)
Intraspecialty
Anesthesiologist 40 75.0 (50.9–91.3) 0.43 (0.01–0.85)
Surgeon 28** 71.4 (41.9–91.6) 0.28 (20.05–0.63)
Public health specialist 40 65.0 (40.8–84.6) 0.30 (20.06–0.66)
Infection control physician 40 55.0 (31.5–76.9) 20.03 (20.45;0.41)
Infection control nurse 40 65.0 (40.8–84.6) 0.40 (20.01–0.80)
Infectious diseases specialist 40 85.0 (62.1–96.8) 0.62 (0.25–1.00)
Microbiologist 40 70.0 (45.7–88.1) 0.41 (0.02–0.80)
Interspecialty 238** - 0.41 (0.34–0.48)
*Number of vignettes scored (for intraspecialty 20 vignettes were scored twice and for interspecialty 34 vignettes were scored 7 times).
**missing values due a computer assignment glitch.
doi:10.1371/journal.pone.0035131.t003
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and organ space SSIs, whereas the infection control team doubled
the number of SSIs by also detecting superficial SSIs [25]. A study
comparing SSI rates from 11 European countries showed
substantial differences in SSI distribution, with the proportion of
superficial SSIs ranging from 80% to 20%–30%, suggesting
differences in SSI detection and/or classification across countries
[26].
Our study further supports the existence of considerable
uncertainty regarding the detection of SSI. Providing the SSI
definition did not change the agreement, except in specialties with
an initially low agreement. Agreement decreased in infection
control physician, without clear explanation. Our results are
probably reliable, as we placed the participants in unbiased
conditions by asking them to score the same case-vignettes through
an Internet database. This method ensured that the participants
were not influenced by factors such as perceived SSI risk in a
particular unit or patient. Considering such factors would likely
have increased disagreement among participants. Thus, SSI rates
may be less than ideal performance indicators. In addition,
mandatory surveillance and public reporting may lead to gaming,
misinterpretation, and underreporting [5,6]. As recently suggested,
there is a need for regular assessments of the reliability and validity
of infection reporting [27].
We found scoring differences across participants and across
types of case-vignettes. As expected, agreement for diagnosis and
superficial/deep SSI assessment were well correlated among
surgeons. More surprisingly, the correlation was poor among
infection control professionals. Our results further support the
need for a multidisciplinary approach to SSI surveillance [28].
Our study has several limitations. First, only one investigator
(DLP) selected the suspected SSI and standardized the vignette. In
addition, each participant worked alone to determine whether SSI
was present in each vignette. SSI is often a difficult diagnosis that
requires discussion among surgeons and infection control
professionals. The main goal of SSI surveillance is accurate SSI
rate determination with feedback of appropriate data to surgeons,
but another goal is to strengthen collaboration between surgical
and infection-control teams in order to implement effective
preventive strategies and to improve quality of care. Our results
indicate that surveillance should not be performed by individuals
in a single specialty [28]. Second, the participants scored vignettes
via an online database. The vignettes were built from real cases,
and the diagnosis of SSI may have been easier for healthcare
professionals who had had direct contact with the patient. Third,
the study was not designed to assess the accuracy of SSI diagnosis.
Instead, we focused on agreement among healthcare professionals
regarding SSI diagnosis. The two main investigators tentatively
classified the vignettes as indicating SSI or no SSI, but their
classification differed for several vignettes. We were therefore
unable to determine which participants made the right diagnosis.
This is illustrated in Table 1, which shows SSI diagnosis score
differences of up to 6 points between two participants from the
same specialty. Fourth, we selected suspicions of SSI to assess the
agreement in the diagnosis of SSI. SSI suspicion however occurs in
a small proportion of patients after surgical procedure. The
Table 4. Assessment of surgical site infection (SSI) depth for 40 vignettes (20 cardiac surgery cases and 20 gastrointestinal surgery
cases) developed based on real patients in three French university hospitals.
Number of vignettes scored* Depth SSI not scored (n, %)*** Kappa coefficient (95%CI)
Scoring without the SSI definition
Intraspecialty correlation
Anesthesiologist 40 9 (22.5) 0.13 (20.14–0.39)
Surgeon 32** 11 (34.4) 0.54 (0.25–0.83)
Public health specialist 40 15 (37.5) 0.32 (0.06–0.59)
Infection control physician 40 13 (32.5) 0.25 (20.04–0.55)
Infection control nurse 40 20 (50.0) 0.10 (20.19–0.38)
Infectious diseases specialist 40 10 (25.0) 0.22 (0.04–0.47)
Microbiologist 40 18 (45.0) 0.21 (20.05–0.46)
Interspecialty correlation 238** 88 (37.0) 0.21 (0.16–0.25)
Scoring with the SSI definition
Intraspecialty correlation
Anesthesiologist 40 13 (32.5) 0.24 (20.03–0.51)
Surgeon 28** 12 (30.0) 0.38 (0.07–0.70)
Public health specialist 40 12 (30.0) 0.15 (20.13–0.44)
Infection control physician 40 13 (32.5) 0.11 (20.15–0.38)
Infection control nurse 40 16 (40.0) 0.41 (20.09–0.72)
Infectious diseases specialist 40 14 (35.0) 0.20 (20.07–0.48)
Microbiologist 40 17 (42.5) 0.10 (20.14–0.33)
Interspecialty correlation 238** 92 (38.7) 0.29 (0.27–0.31)
SSI Depth was scores on a 4-point scale: scale 1, no SSI in vignettes with scores lower than 4 on the 7-point Likert for the absence/presence of SSI; scale 2, superficial SSI;
scale 3, uncertainty about SSI diagnosis, scale 4, deep/organ space SSI in vignettes scored 4 or more on the 7-point Likert scale.
*For intraspecialty 20 vignettes were scored twice and for interspecialty 34 vignettes were scored 7 times).
**missing values due a computer assignment glitch.
***Depth was not scored because scores of the absence/presence of SSI were lower than 4 on the 7-point Likert scale.
doi:10.1371/journal.pone.0035131.t004
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the heterogeneity of the population had been greater, e.g., if the
population studied have been an actual series of surgical patients
rather than a series of surgical patients with suspected infection.
Fifth, the study was performed in a country where specific SSI
surveillance method and practice are used. Results might have
been different in another country. Finally, we selected case-
vignettes in only two surgical specialties, representing clean and
contaminated surgery, respectively. Increasing the spectrum of
surgical procedures would probably have increased the degree of
disagreement regarding SSI diagnosis and depth assessment. For
example, SSI may be particularly difficult to diagnose in the
absence of a skin incision, e.g., after vaginal hysterectomy or
transurethral resection of the prostate.
In conclusion, among healthcare professionals evaluating case-
vignettes for possible surgical site infection, there was large
disagreement in diagnosis that varied both between and within
specialties. These results support a multidisciplinary approach for
SSI diagnosis. Our finding supports the need for caution when
using SSI rates for benchmarking or requiring public reporting of
SSI rates. Similar concerns have been voiced regarding other
publicly reported infection rates, such as rates of catheter-related
bloodstream infections [29,30] or ventilator-associated pneumonia
[31] in critically ill patients. Nevertheless, SSI surveillance and
feedback remain important tools for SSI prevention [32]. Further
studies are needed to improve agreement regarding the diagnosis
of SSI.
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MD, University Hospital, Lyon; Thierry Lepoivre, MD, University
Hospital, Nantes; Philippe Montravers, MD, PhD, Bichat-Claude Bernard
University Hospital, Paris; Catherine Paugam, MD, PhD, Beaujon
University Hospital, Clichy; Sebastian Pease, MD, Beaujon University
Hospital, Clichy; Alain Peron, MD, Nantes Private Hospital, Reze ´; Yvan
Philip, MD, Bichat-Claude Bernard University Hospital, Paris; Jean Petri,
MD, Montsouris Institute, Paris; Jean-Christophe Rigal, MD, University
Hospital, Nantes; Jean Tourres, Atlantic Hospital, St Herblain; Daniel
Villers, MD, PhD, University Hospital, Nantes; Jean-Fabien Zazzo, MD,
Antoine Be ´cle `re University Hospital, Clamart.
Surgeons: Be ´atrice Barry, MD, PhD, Bichat-Claude Bernard Univer-
sity Hospital, Paris; Eric Bord, MD, University Hospital, Nantes; Denis
Chosidow, MD, Bichat-Claude Bernard Univsersity Hospital, Paris;
Se ´bastien Contios, MD, Morlaix Hospital, Morlaix; Olivier Farges, MD,
Beaujon University Hospital, Clichy; Christophe Ferron, MD, University
Hospital, Nantes; Ce ´cile Jeanrot, MD, Bichat-Claude Bernard University
Hospital, Paris; Jean-Claude Jouven, MD, St Joseph Hospital, Marseille;
Michel Kitzis, MD, Ambroise Pare ´ University Hospital, Boulogne; Jean-
Michel Maury, MD, Bichat-Claude Bernard University Hospital, Paris;
Jean-Pierre Mignard, MD, Saint Brieuc Hospital, Saint Brieuc; Ve ´ronique
Molina, MD, Bice ˆtre University Hospital, Le Kremlin Bice ˆtre; Sophie
Omnes, MD, Bichat-Claude Bernard University Hospital, Paris; Chris-
tophe Poncelet, MD, PhD, Jean Verdier University Hospital, Bondy; Loı ¨c
Sauvage, MD, Nantes Private Hospital, Reze ´; Didier Signorelli, MD, Jules
Verne Hospital, Nantes; Mohamed Touam, MD, Championnet Hospital,
Paris; Sophie Touchais, MD, University Hospital, Nantes; Philippe Vernet,
MD, CMCM Po ˆle Sante ´ Sud, Le Mans; FarhanYasdani, MD, Carhaix
Hospital, Plouguer.
Public health specialists: He ´le `ne Abbey, MD, University Hospital,
Nantes; Gilles Antoniotti, PharmD, Ge ´ne ´rale de Sante ´, Paris; Dalila
Benabderahmane, MD, Bichat-Claude Bernard University Hospital, Paris;
Adel Bouakline, RT, Auxerre Hospital, Auxerre; Bruno Coignard, MD,
National Institute of Health (InVS), St Maurice; Nathalie Di Carmine, RN,
Avicenne University Hospital, Bobigny; Sophie Ferre ´ol, MD, University
Hospital, Nantes; Ve ´ronique Gilleron, MD, Pellegrin University Hospital,
Bordeaux; Bruno Hubert, MD, CIRE Pays de la Loire, Nantes; Bertrand
Le Corre, RN, Bichat-Claude Bernard University Hospital, Paris; Annick
Macrez, RN, Bichat-Claude Bernard University Hospital, Paris; Isabelle
Mahe-Galisson, RT, University Hospital, Nantes; Leila Moret, MD, PhD,
University Hospital, Nantes; Nathalie Nion, RN, Pitie ´-Salpe ˆtrie `re
University Hospital, Paris; Marie-Laure Pibarot, MD, PhD, Assistance
publique de Paris, Paris; Isabelle Poujol, RN, National Institute of Health
(InVS), St Maurice; Jean-Luc Quenon, MD, CCECQA, Bordeaux; Jean-
Claude Re ´veil, RN, Charleville-Me ´zie `res Hospital, Charleville-Me ´zie `res;
Michel Sfez, MD, St Jean-de-Dieu Hospital, Paris; Caroline Te ´tard, RT,
University Hospital, Nantes.
Infection control physicians: Odile Bajolet, MD, University
Hospital, Reims; Fre ´deric Barbut, MD, PhD, Saint Antoine University
Hospital, Paris; Raoul Baron, MD, University Hospital, Brest; Jean-
Winock Decousser, MD, Antoine Be ´cle `re University Hospital, Clamart;
Vincent Fihman, MD, Louis Mourier University Hospital, Colombes;
Nicolas Fortineau, MD, Bice ˆtre University Hospital, Le Kremlin Bicetre;
Raphaelle Girard, MD, University Hospital, Lyon; Jean-Michel Gue ´rin,
MD, Lariboisie `re University Hospital, Paris; Bruno Jarrige, MD,
University Hospital, Pointe-a `-Pitre; Olivia Keita-Perse, MD, Princess
Grace Hospital, Monaco; Caroline Landelle, MD, PhD, Henri Mondor
University Hospital, Cre ´teil; Virginie Loubersac, MD, Nantes Private
Hospital, Reze ´; Gilles Manquat, MD, Chambery Hospital, Chambery;
Jacques Merrer, MD, Andre ´ Mignot Hospital, Versailles; Ste ´phanie
Perron, PharmD, Saumur Hospital, Saumur; Anne-Marie Rogues, MD,
PhD, University Hospital, Bordeaux; Jacques Se ´guier, MD, Poissy-St
Germain Hospital; Daniel Talon, MD, University Hospital, Besanc ¸on;
Ousmane Traore ´, MD, PhD, University Hospital, Clermont-Ferrand;
Xavier Verdeil, MD, University Hospital, Toulouse.
Infection control nurses: Sandrine Barquins, RT, Lariboisie `re
University Hospital, Paris; Joe ¨lle Be ´rard, RN, Princess Grace Hospital,
Monaco; Laurence Cauchy, RN, University Hospital, Lille; Jean-Pierre
Claisse, RN, Saint Louis University Hospital, Paris; Be ´atrice Croze, RN,
Valence hospital, Valence; Marie-France Deberles, RN, Oscar Lambert
Hospital, Lille; Franc ¸oise Debosche `re, RN, Louvie `re Hospital, Lille;
Vale ´rie Delbos, RN, University Hospital, Angers; Catherine Dessaux,
He ´nin Beaumont Hospital, He ´nin-Beaumont; Genevie `ve Dobremetz, RN,
Opale Hospital, Berck; ; Fabienne Gonfier, RN, Lariboisie `re University
Hospital, Paris; Anne-Claire Guille des Buttes, RN, University Hospital,
Nantes; Christine Hovasse, RN, Lariboisie `re University Hospital, Paris;
Sophie Lefebvre, RN, Saint Omer Hospital, Saint Omer; Marie-Franc ¸oise
Mathelin, RN, GHICL, Lille; Dominique Matouk, RN, Nantes Private
Hospital, Reze ´; Laurence Mordelet, RN, University Hospital, Nantes;
Monique Picard, RN, University Hospital, Nantes.
Infectious diseases specialists: Sophie Abgrall, MD, University
Hospital, Bobigny; Serge Alfandari, MD, University Hospital, Tourcoing;
David Boutoille, MD, University Hospital, Nantes; Elisabeth Bouvet, MD,
Bichat-Claude Bernard University Hospital, Paris; Bernard Garo, MD,
University Hospital, Brest; Olivier Grossi, MD, Nantes Private Hospital,
Reze ´; Benoit Gue ´ry, MD, University Hospital, Lille; Flore Lacassin, MD,
Noume ´a Hospital, Noume ´a; Mathieu Lafaurie, MD, Saint Louis
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Hospital, Cre ´teil; Jean-Luc Mainardi, MD, PhD, Georges Pompidou
University Hospital, HEGP, Paris; Ve ´ronique Re ´my, MD, Cahors
Hospital, Cahors; Christophe Rioux, MD, Bichat-Claude Bernard
University Hospital, Paris; Mathieu Saada, MD, Perpignan Hospital,
Perpignan; Jean-Pierre Sollet, MD, Argenteuil Hospital, Argenteuil; Pierre
Tattevin, MD, PhD, University Hospital, Rennes; Jean-Louis Trouillet,
MD, Pitie ´-Salpe ˆtrie `re University Hospital, Paris; Yazdan Yazdanpanah,
MD PhD, University Hospital, Tourcoing.
Microbiologists: Antoine Andremont, MD, PhD, Bichat-Claude
Bernard University Hospital, Paris; Laurence Armand-Lefe `vre, MD,
PhD, Bichat-Claude Bernard University Hospital, Paris; Pascale Bemer,
MD, University Hospital, Nantes; Je ´ro ˆme Besson, PharmD, Biolance
Laboratory, Nantes; Catherine Branger, MD, PhD, Louis Mourier
University Hospital, Colombes; Anne Cady, PharmD, University hospital,
Rennes; Guy Cheviet, MD, Biolance Laboratory, Nantes; Stephane
Corvec, MD, PhD, University Hospital, Nantes; Lise Cre ´met, PharmD,
university Hospital, Nantes; Dominique Decre ´, PharmD, PhD, St Antoine
University Hospital, Paris; Pierre-Edouard Fournier, MD, PhD, University
Hospital, Marseille; Sylvie Gabriel, MD, Princess Grace Hospital, Monaco;
Marie-Laure Joly-Guillou, MD, PhD, University Hospital, Angers; Marie-
Fre ´de ´rique Lartigue, MD, PhD, University Hospital, Tours; Jean-Philippe
Lavigne, MD, PhD, University Hospital, Nı ˆmes; Ve ´ronique Leflon, MD,
Beaujon University Hospital, Clichy; Yves Pe ´an, MD, Montsouris Institut,
Paris; Martine Rouveau, MD, Saint Louis University Hospital, Paris;
Didier Tande ´, PharmD, University Hospital, Brest; Paul-Louis Woerther,
MD, Bichat-Claude Bernard University Hospital, Paris.
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